from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3046c/-

LFCtreatmentdescriptionclass of inhibitor

-0.933

Amikacinug/mL Amikacintranslation

-0.744

Cap5-10ug/mL Capreomycintranslation

0.157

Rox10-50 ug/mL Roxithromycintranslation

-0.707

SM2-5 ug/mL Streptomycintranslation

-1.039

Tet5-10 ug/mL Tetracyclinetranslation

-0.622

Rif0.2-5ug/mL Rifampicintranscription

-1.013

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.337

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

4.217

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.318

CPZ10-50 ug/mL Chlorpromazinerespiration

0.063

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.328

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.880

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.111

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.355

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.061

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.150

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.323

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.771

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.371

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.297

KCN5-20 ug/mL Potassium cyaniderespiration

-0.117

NaN30.2-2 mM Sodium aziderespiration

0.700

Nigericin50 uM Nigericinrespiration

0.510

TRC10-150 ug/mL Triclosanrespiration

1.760

TRZ10-25 ug/mL Thioridazinerespiration

0.484

Valinomycin0.5-10 uM Valinomycinrespiration

0.323

ZnSO42 mM ZnSO4respiration

1.314

menadione6-10 ug/mL Menadionerespiration

-0.357

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.516

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.048

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.071

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.012

NRP_1Non-replicating persistence stage 1dosRassociated

-0.397

Amp0.2mg/mL AmpicillincellWall

0.108

Cephalexin20-100 ug/mL CephalexincellWall

-0.355

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.228

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.268

EMB10-20 ug/mL EthambutolcellWall

0.366

Eta12-40 ug/mL EthionamidecellWall

-0.366

INH0.2-0.4 ug/mL IsoniazidcellWall

0.251

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.617

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.187

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.724

BZA0.12 mg/mL BenzamidearomaticAmides

-0.727

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.249

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.391

H2O24 mM hydrogen peroxideDNAdamaging

0.053

Levo10 ug/mL LevofloxacinDNAdamaging

-0.726

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.609

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.010

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.440

UVUV-irradiationDNAdamaging

2.841

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.418

Antimycin12.5-50 ug/mL Antimycin A?

-0.080

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.541

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.465

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.194

PA8240.2-2 ug/mL PA-824?

0.176

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.095

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.118

Verapamil50 uM Verapamil?

-0.299

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.471

methoxatin10-20 ug/mL Methoxatin?